RELATED CONTENT
NEWS
- Sepracor gains US patent extension for top product
- US health reform bill: Senate's work may be done, but difficult issues on conference
- US FTC against 12-14 years of exclusivity for innovator biologics
- Isis's mipomersen passes second Phase III trial, but safety concerns spook investors
EVENTS
Today
Berlin, Germany
Today
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009


